BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38858309)

  • 21. Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).
    Carter MT; Srour M; Au PB; Buhas D; Dyack S; Eaton A; Inbar-Feigenberg M; Howley H; Kawamura A; Lewis SME; McCready E; Nelson TN; Vallance H;
    J Med Genet; 2023 Jun; 60(6):523-532. PubMed ID: 36822643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Testing Practices of Genetic Counselors, Geneticists, and Pediatric Neurologists With Regard to Childhood-Onset Neurogenetic Conditions.
    Wofford S; Noblin S; Davis JM; Farach LS; Hashmi SS; Mancias P; Wagner VF
    J Child Neurol; 2019 Mar; 34(4):177-183. PubMed ID: 30608006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal Microarray in Patients with Non-Syndromic Autism Spectrum Disorders in the Clinical Routine of a Tertiary Hospital.
    Sandoval-Talamantes AK; Mori MÁ; Santos-Simarro F; García-Miñaur S; Mansilla E; Tenorio JA; Peña C; Adan C; Fernández-Elvira M; Rueda I; Lapunzina P; Nevado J
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can clinical characteristics be criteria to perform chromosomal microarray analysis in children and adolescents with autism spectrum disorders?
    Sys M; van den Bogaert A; Roosens B; Lampo A; Jansen A; Wouters S; Keymolen K
    Minerva Pediatr; 2018 Jun; 70(3):225-232. PubMed ID: 27607483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Short Stature: A Systematic Review and Meta-Analysis.
    Li Q; Chen Z; Wang J; Xu K; Fan X; Gong C; Wu Z; Zhang TJ; Wu N
    JAMA Pediatr; 2023 Nov; 177(11):1149-1157. PubMed ID: 37695591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism spectrum disorder and genetic testing: Parental perceptions and decision-making.
    Hanish AE; Cohen MZ; Starr LJ
    J Spec Pediatr Nurs; 2018 Apr; 23(2):e12211. PubMed ID: 29473279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do the data really support ordering fragile X testing as a first-tier test without clinical features?
    Weinstein V; Tanpaiboon P; Chapman KA; Ah Mew N; Hofherr S
    Genet Med; 2017 Dec; 19(12):1317-1322. PubMed ID: 28541279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Yield of Exome Sequencing in Cerebral Palsy and Implications for Genetic Testing Guidelines: A Systematic Review and Meta-analysis.
    Gonzalez-Mantilla PJ; Hu Y; Myers SM; Finucane BM; Ledbetter DH; Martin CL; Moreno-De-Luca A
    JAMA Pediatr; 2023 May; 177(5):472-478. PubMed ID: 36877506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis.
    Stefanski A; Calle-López Y; Leu C; Pérez-Palma E; Pestana-Knight E; Lal D
    Epilepsia; 2021 Jan; 62(1):143-151. PubMed ID: 33200402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring genetic testing requests, genetic alterations and clinical associations in a cohort of children with autism spectrum disorder.
    Garrido-Torres N; Marqués Rodríguez R; Alemany-Navarro M; Sánchez-García J; García-Cerro S; Ayuso MI; González-Meneses A; Martinez-Mir A; Ruiz-Veguilla M; Crespo-Facorro B
    Eur Child Adolesc Psychiatry; 2024 Apr; ():. PubMed ID: 38587680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.
    Baio J; Wiggins L; Christensen DL; Maenner MJ; Daniels J; Warren Z; Kurzius-Spencer M; Zahorodny W; Robinson Rosenberg C; White T; Durkin MS; Imm P; Nikolaou L; Yeargin-Allsopp M; Lee LC; Harrington R; Lopez M; Fitzgerald RT; Hewitt A; Pettygrove S; Constantino JN; Vehorn A; Shenouda J; Hall-Lande J; Van Naarden Braun K; Dowling NF
    MMWR Surveill Summ; 2018 Apr; 67(6):1-23. PubMed ID: 29701730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
    Yuen T; Carter MT; Szatmari P; Ungar WJ
    Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic profile and clinical application of chromosomal microarray in children with intellectual disability in Hong Kong.
    Chan PY; Luk HM; Lee FM; Lo IF
    Hong Kong Med J; 2018 Oct; 24(5):451-459. PubMed ID: 30262673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Associated With Underutilization of Genetic Testing in Autism Spectrum Disorders.
    Abreu NJ; Chiujdea M; Liu S; Zhang B; Spence SJ
    Pediatr Neurol; 2024 Jan; 150():17-23. PubMed ID: 37939453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices.
    Peabody J; Martin M; DeMaria L; Florentino J; Paculdo D; Paul M; Vanzo R; Wassman ER; Burgon T
    PLoS One; 2016; 11(12):e0169064. PubMed ID: 28036350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Diagnostic Exome Sequencing in Patients With Diagnosed or Suspected Autism Spectrum Disorders.
    Rossi M; El-Khechen D; Black MH; Farwell Hagman KD; Tang S; Powis Z
    Pediatr Neurol; 2017 May; 70():34-43.e2. PubMed ID: 28330790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exome sequencing as first-tier test for fetuses with severe central nervous system structural anomalies.
    Yaron Y; Ofen Glassner V; Mory A; Zunz Henig N; Kurolap A; Bar Shira A; Brabbing Goldstein D; Marom D; Ben Sira L; Baris Feldman H; Malinger G; Krajden Haratz K; Reches A
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):59-67. PubMed ID: 35229910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach.
    Fernandez BA; Scherer SW
    Dialogues Clin Neurosci; 2017 Dec; 19(4):353-371. PubMed ID: 29398931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.